not just DTC genomics, but all medical genetics. Putting an FH test next to one for wine cheapens legitimately actionable genetic tests
-
-
-
Agreed. That's the main issue here - so much promise for medical genetics going forward, but will get obscured by bs if we're not careful.
- Nog 3 antwoorden
Nieuw gesprek -
-
-
I disagree. Nothing quick on my part - I have followed this space closely. The rush is on the side of releasing the 'AppStore' prematurely.
Bedankt, Twitter gebruikt dit om je tijdlijn te verbeteren. Ongedaan makenOngedaan maken
-
-
-
Misrepresenting science and diluting an incredibly important (future) market will not achieve that. We need facts and science - not hype.
-
Heard the head of KPMG China say just the same thing -> both of you guys think alike ;-)
Einde van gesprek
Nieuw gesprek -
-
-
Lack of scientific evidence baked in with hyped claims muddling genomics-based medical research has that effect on me. Sorry.

-
+1 (spending lots of time in Asia, including China). Will i get to own my data?...
Einde van gesprek
Nieuw gesprek -
-
-
Starting with premature apps is premature - you dilute your model. Why not wait for strong apps from strong science/developers? Like Mayo?
-
As a Mayo-educated DNA app developer, I can assure you we've been around for a long time but the press hardly notices. Many apps out there
- Nog 1 antwoord
Nieuw gesprek -
-
-
Nothing wrong with what Helix has to offer. However not offering a medical advice devalues the service.
-
I disagree. There's everything wrong with the current offering. Diluting the market of useful science-based tests and confusing customers.
- Nog 1 antwoord
Nieuw gesprek -
Het laden lijkt wat langer te duren.
Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.
.